Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

May 2020 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2020. This roundup includes...
Insulin infusion helps achieve glycemic targets and may reduce the risk for poor outcomes in patients with hyperglycemia and COVID-19

Improving Glycemic Control May Also Aid COVID-19 Outcomes

Insulin infusion may reduce risk for severe disease in those with hyperglycemia and COVID-19
For patients with diabetes and COVID-19

Age, CRP Up Risk for Mortality in Diabetes With COVID-19

Insulin usage linked to poor prognosis; ACEI/ARB use did not impact clinical outcome in those with HTN
Higher intake of whole-fat dairy products is associated with a lower prevalence of metabolic syndrome as well as hypertension and diabetes

Higher Intake of Whole-Fat Dairy May Cut Metabolic Syndrome Risk

Similar associations found for hypertension, diabetes in large multinational cohort study
Changes in total lean body mass with aging are associated with the development of diabetes among men and women

Lower Lean Body Mass With Aging May Up Diabetes Incidence in Men

Men and women with higher absolute lean body mass also have greater incidence of diabetes
Use of sodium-glucose cotransporter 2 inhibitors is associated with a reduced risk for serious renal events compared with dipeptidyl peptidase-4 inhibitors

SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events

Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors

April 2020 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2020. This roundup includes...
Pharmacologic treatment for type 2 diabetes increased from 2003 to 2016

Diabetes Medication Prescribing Increased 2003 to 2016

However, authors say there is little evidence that doctors are tailoring treatment for patients
Diabetes and/or uncontrolled hyperglycemia occur frequently among hospitalized patients with COVID-19 and are associated with worse outcomes

COVID-19 Outcomes Worse With Diabetes, Hyperglycemia

Length of stay longer, mortality higher for those with diabetes and/or acutely uncontrolled hyperglycemia
The most common comorbidities among patients hospitalized with COVID-19 in the New York City area are hypertension

HTN, Obesity, Diabetes Common in U.S. COVID-19 Patients

Twenty-one percent of hospitalized patients died; 88.1 percent requiring mechanical ventilation died